PacBio to Participate in the Morgan Stanley 24ᵗʰ Annual Global Healthcare Conference
PacBio will webcast its September 15, 2026 Morgan Stanley healthcare conference fireside chat with a replay available for at least 30 days.
Rhea-AI Summary
PacBio (PACB) will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference on Tuesday, September 15, 2026, at 4:50 PM ET in New York.
A live webcast and a replay, available for at least 30 days, can be accessed via PacBio’s investor relations website at investor.pacificbiosciences.com.
Positive
- None.
Negative
- None.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Aug 05 | Leadership change | Neutral | -10.4% | Appointment of a new CEO was followed by a negative 24-hour price reaction. |
| Aug 05 | Quarterly earnings | Negative | -10.4% | Earnings release reported Q2 revenue below the prior-year quarter and a net loss. |
| Aug 05 | Product update | Positive | -9.7% | Product update announced higher output and lower per-run pricing. |
| Jul 28 | Conference participation | Neutral | +0.7% | Conference fireside-chat participation announcement preceded a 0.72% 24-hour move. |
| Jul 15 | Earnings scheduling | Neutral | -2.6% | Earnings-date scheduling notice preceded a -2.61% 24-hour move. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent history showed negative reactions to the August 5 leadership and product announcements, while the prior conference notice preceded a positive move; responses were mixed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MENLO PARK, Calif., Sept. 03, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference on Tuesday, September 15, 2026, at 4:50 PM ET in New York, New York.
A live webcast of the event can be accessed at the company’s investors page at investor.pacificbiosciences.com. A replay of the webcast will be available for at least 30 days following the event.
About PacBio
PacBio (NASDAQ: PACB) is a premier life science technology company that designs, develops, and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. Our products and technologies, which include our HiFi long-read sequencing, address solutions across a broad set of research applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. For more information, please visit www.pacb.com and follow @PacBio.
PacBio products are provided for Research Use Only. Not for use in diagnostic procedures.
Contacts
Investors:
ir@pacb.com
Media:
pr@pacb.com
